1
TITLE: Decoding the secrets: how conformational and structural regulators inhibit the human 20S proteasome
AUTHORS: Fernandes, Pedro M. P.; Guedes, Romina A.; Victor, Bruno L.; Salvador, Jorge A. R.; Guedes, Rita C.;
PUBLISHED: 2024, SOURCE: FRONTIERS IN CHEMISTRY, VOLUME: 11
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
2
TITLE: Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?
AUTHORS: Ângela Gonçalves; Mariana Matias; Jorge R Salvador; Samuel Silvestre;
PUBLISHED: 2024, SOURCE: International Journal of Molecular Sciences, VOLUME: 25, ISSUE: 3
INDEXED IN: Scopus CrossRef: 2
IN MY: ORCID
3
TITLE: PROteolysis-Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
AUTHORS: Vicente, Andre T. S.; Salvador, Jorge A. R.;
PUBLISHED: 2024, SOURCE: MEDCOMM, VOLUME: 5, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
4
TITLE: BACE1 Inhibitors for Alzheimer’s Disease: Current Challenges and Future Perspectives
AUTHORS: Judite R.M Coimbra; Rosa Resende; José B.A Custódio; Jorge A.R Salvador; Armanda E Santos;
PUBLISHED: 2024, SOURCE: Journal of Alzheimer's Disease
INDEXED IN: CrossRef
IN MY: ORCID
5
TITLE: Bi- and tricyclic diterpenoids: landmarks from a decade (2013-2023) in search of leads against infectious diseases  Full Text
AUTHORS: Antoniuk, Olha; Maranha, Ana; Salvador, Jorge A. R.; Empadinhas, Nuno; Moreira, Vania M.;
PUBLISHED: 2024, SOURCE: NATURAL PRODUCT REPORTS
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
6
TITLE: Recent advances in oridonin derivatives with anticancer activity
AUTHORS: Sobral, Pedro J. M.; Vicente, Andre T. S.; Salvador, Jorge A. R.;
PUBLISHED: 2023, SOURCE: FRONTIERS IN CHEMISTRY, VOLUME: 11
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID
7
TITLE: Proteolysis-Targeting Chimeras (PROTACs) targeting the BCR-ABL for the treatment of chronic myeloid leukemia - a patent review
AUTHORS: Vicente, Andre T. S.; Salvador, Jorge A. R.;
PUBLISHED: 2023, SOURCE: EXPERT OPINION ON THERAPEUTIC PATENTS, VOLUME: 33, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
8
TITLE: New Scaffolds of Proteasome Inhibitors: Boosting Anticancer Potential by Exploiting the Synergy of In Silico and In Vitro Methodologies
AUTHORS: Guedes, Romina A.; Grilo, Jorge H.; Carvalho, Andreia N.; Fernandes, Pedro M. P.; Ressurreicao, Ana S.; Brito, Vanessa; Santos, Adriana O. ; Silvestre, Samuel; Gallerani, Eleonora; Gama, Maria Joao; Gavioli, Riccardo; Salvador, Jorge A. R.; Guedes, Rita C.;
PUBLISHED: 2023, SOURCE: PHARMACEUTICALS, VOLUME: 16, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
9
TITLE: Therapeutic potential of glutaminyl cyclases: Current status and emerging trends  Full Text
AUTHORS: Coimbra, Judite R. M.; Moreira, PI; Moreira, Paula Isabel; Paula I. Moreira ; Santos, Armanda E.; Salvador, Jorge A. R.;
PUBLISHED: 2023, SOURCE: DRUG DISCOVERY TODAY, VOLUME: 28, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 6
IN MY: ORCID
10
TITLE: Ubiquitin-specific protease 7 (USP7): an emerging drug target for cancer treatment
AUTHORS: Carreira, Laura D.; Oliveira, Rita I.; Moreira, Vania M.; Salvador, Jorge A. R.;
PUBLISHED: 2023, SOURCE: EXPERT OPINION ON THERAPEUTIC TARGETS, VOLUME: 27, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
Page 1 of 9. Total results: 84.